Logout Login Cart iconShop
Contact Sales

Search

Filters

Content Type

Products

Clear Filters

Search Results for "Alternating Tangential Flow Filtration関連"

Looking for quality documents?
publications icon
KB19003 FlowVPE Software-Security Configuration Windows 710-32-64 CaryWinUV Article
publications icon
KB23002 PATsmart ViPER and SecureVPT Software for FlowVPX System - Suggested User Access Level Table
publications icon
Genentech: FlowVPE System – Evaluation of Variable Pathlength Technology Publication
corporate icon
KrosFlo® KR2i RPM™ System
TFF with In-Line Protein Concentration Management Monitor concentration in real time during your UF/DF run. Featuring in-line protein concentration management, control your process with the power of the KrosFlo® KR2i TFF System and insights from the integrated CTech™ FlowVPX® System.
external link icon
Repligen Acquires Bioprocessing Business of Refine Technology
- Expands Portfolio of Products to Improve Efficiencies in Biologic Drug Manufacturing - - Company Updates 2014 Financial Guidance - - Conference Call and Webcast Today at 9:00 a.m. EDT - WALTHAM, Mass., June 3, 2014 (GLOBE NEWSWIRE) - Repligen Corporation (Nasdaq:RGEN) announced today that it has acquired the business of Refine Technology ("Refine"), including Refine's Alternating Tangential Flow ("ATF") System, a market-leading device used to significantly increase product yield during the fermentation step of the biologic drug manufacturing process. The acquisition strengthens Repligen's bioprocessing business by adding a profitable and highly complementary product line while expanding the Company's direct sales presence worldwide. Repligen has entered into a definitive agreement effective June 2, 2014 to purchase Refine's business for a combination of $20.5 million in cash and 215,285 shares of Repligen common stock, for total upfront consideration of approximately $24.5 million.
corporate icon
KrosFlo® FS-15 RPM™ System
Discover the KrosFlo® FS-15 RPM™ System, part of our RPM™ (Real-time Process Management) Series, designed to revolutionize process control in bioprocessing. Integrating the CTech™ FlowVPX® in-line spectrophotometer, our system provides real-time insights and PAT-control over UF/DF processes, enhancing efficiency, quality, and productivity.
external link icon
Repligen Completes Expansion of U.S. Facility
WALTHAM, Mass., Feb. 10, 2015 (GLOBE NEWSWIRE) - Repligen Corporation (Nasdaq:RGEN) announced today that it has completed an 11,000 square foot expansion of its U.S. manufacturing facility. The expansion includes a dedicated space for the production and assembly of Repligen's Alternating Tangential Flow System ("the ATF System"), the most recent addition to the Company's upstream bioprocessing product portfolio. The ATF System is a market-leading product line used to significantly increase cell density and product yield during the fermentation step of the biologic drug manufacturing process. The expansion includes areas for ATF System assembly, quality control and inventory, as well as cleanroom suites for the production of single-use ATF Systems in an ISO 7 environment that meets the high standards of Repligen's biopharmaceutical customers. "This expansion satisfies our goal to rapidly transfer ATF System operations, which we acquired from Refine Technology of
corporate icon
Scalable UV Light Source Solutions
UV Light Source Solutions for Variable Pathlength Spectroscopy From multiwavelength spectrophotometer to GMP-compatible single-wavelength solutions, our interchangeable light sources seamlessly integrate with the PATsmart™ FlowVPX® System to address your diverse research, process development, and manufacturing needs.
corporate icon
PATsmart™ MAVEN® Online Glucose and Lactate Monitoring
Take command of your cell culture process with the PATsmart™ MAVEN® Online Glucose and Lactate Monitoring System. Delivering continuous, sample-free glucose data every 2 minutes, MAVEN automates feeding strategies, reduces variability, and frees your team from manual sampling. Built to integrate seamlessly, it brings precision and efficiency to every run—without disrupting your workflow.
external link icon
UPDATE -- Repligen Acquires TangenX Technology Corporation
WALTHAM, Mass., Dec. 15, 2016 (GLOBE NEWSWIRE) - Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has acquired TangenX Technology Corporation (“TangenX”) of Shrewsbury, MA, maker of the innovative single-use Sius™ line of tangential flow filtration (“TFF”) cassettes and hardware used in downstream biopharmaceutical manufacturing processes.  Sius TFF is used in the filtration of biological drugs, complementing Repligen’s OPUS® line of Pre-Packed Chromatography Columns used in downstream purification. Single-use Sius TFF cassettes are designed to deliver superior performance to traditional (reusable) TFF cassettes in a cost-competitive format that provides user-ready convenience and flexibility. The Sius portfolio also strengthens the Company’s existing capability in filtration, where its XCell™ ATF products (both stainless steel and single-use) are used for perfusion and cell culture intensification
Close modal

A new look. A better way to explore Repligen.

We’ve redesigned Repligen.com to help you find the right solutions faster, with greater clarity and less effort.

Find what you need faster
Get to the right information with quicker site speed

Explore the site with ease
Navigate easily with an intuitive, simple site structure

Access product details instantly
Find products and resources faster, in fewer clicks

Get support when you need it
Connect with our team when you need support